PARKHOSPSBSEPark Medi World LtdMediumNeutral
Announced Fri, 15 May · 16:47 IST

Transcript of Earnings Conference Call held on May 13, 2026

Promoter Disclosed Acquisition PlansCfo Debt Reduction RoadmapInvestor Communications View source PDF

PARKHOSPS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.1%1-day move
₹242.20
prior close
₹244.46
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.2-0.7-0.4+2.1+5.2+5.7+6.8+14.9+18.5+21.1+5.5+16.0
Up moveDown movePending
AI summary

Park Medi World delivered its best-ever financial performance in FY26 with revenue of INR1,679 crores (up 21% YoY), EBITDA of INR444 crores (up 20%), and PAT of INR274 crores (up 27%). The company added 610 beds during the year, taking total capacity to 3,610 beds, including new hospitals in Bathinda (250 beds) and Agra (360 beds). A 350-bed Greenfield facility in Panchkula was commissioned on April 10, 2026, and a 200-bed acquisition in Narela, Delhi under IBC is expected to be commissioned in Q2 FY27. The company targets reaching 5,460 beds by March 2028 with 1,500 beds currently under execution. Management expects the CGHS rate hike to contribute 5-6% revenue impact in FY27, and targets EBITDA positivity for the Agra facility in the current year. The balance sheet remains strong with gross debt reduced to just INR28 crores and operating cash flow of INR329 crores for FY26.

Likely market impact

The company demonstrated strong operational efficiency and financial discipline with PAT margins expanding by 83 basis points. The significant debt reduction and robust cash generation provide funding visibility for future growth plans, while the CGHS rate hike should support revenue growth in FY27.